Saya Jacob

618 total citations
27 papers, 363 citations indexed

About

Saya Jacob is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Saya Jacob has authored 27 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Saya Jacob's work include Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Saya Jacob is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (7 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Saya Jacob collaborates with scholars based in United States, Italy and India. Saya Jacob's co-authors include Hope S. Rugo, Erika Hamilton, Mythili Shastry, Amir Behdad, Ami N. Shah, Massimo Cristofanilli, Lorenzo Gerratana, William J. Gradishar, Lisa Flaum and Firas Wehbe and has published in prestigious journals such as Journal of Clinical Oncology, Diabetes Care and Cancer Research.

In The Last Decade

Saya Jacob

25 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Saya Jacob United States 11 226 136 116 89 43 27 363
Minghan Jia China 10 206 0.9× 127 0.9× 102 0.9× 133 1.5× 48 1.1× 21 394
Nicoletta Provinciali Italy 9 175 0.8× 119 0.9× 54 0.5× 83 0.9× 23 0.5× 22 308
Benedetta Pellegrino Italy 11 205 0.9× 84 0.6× 124 1.1× 95 1.1× 43 1.0× 34 351
Shinsuke Tasaki Japan 11 99 0.4× 69 0.5× 154 1.3× 94 1.1× 31 0.7× 30 365
Netanya Pollock United States 8 158 0.7× 77 0.6× 58 0.5× 140 1.6× 24 0.6× 11 322
Xiaojun Fan China 9 138 0.6× 202 1.5× 76 0.7× 180 2.0× 20 0.5× 20 378
Lauren Nye United States 9 270 1.2× 115 0.8× 76 0.7× 58 0.7× 34 0.8× 37 369
Jennifer Marks Canada 8 235 1.0× 124 0.9× 302 2.6× 248 2.8× 23 0.5× 15 644
Xinnian Yu China 13 82 0.4× 138 1.0× 84 0.7× 182 2.0× 19 0.4× 21 360
Quchang Ouyang China 10 270 1.2× 69 0.5× 151 1.3× 65 0.7× 59 1.4× 52 363

Countries citing papers authored by Saya Jacob

Since Specialization
Citations

This map shows the geographic impact of Saya Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saya Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saya Jacob more than expected).

Fields of papers citing papers by Saya Jacob

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saya Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saya Jacob. The network helps show where Saya Jacob may publish in the future.

Co-authorship network of co-authors of Saya Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Saya Jacob. A scholar is included among the top collaborators of Saya Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saya Jacob. Saya Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gerratana, Lorenzo, Andrew A. Davis, Paolo D’Amico, et al.. (2024). Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA. Clinical Cancer Research. 30(16). 3470–3480. 2 indexed citations
3.
Jacob, Saya, Hongmei Yu, Gillian L. Hirst, et al.. (2024). Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy. Breast Cancer Research and Treatment. 209(1). 147–159. 1 indexed citations
4.
Jacob, Saya, Hongmei Yu, Denise M. Wolf, et al.. (2023). Use of PROMIS to capture patient reported outcomes over time for patients on I-SPY2.. Journal of Clinical Oncology. 41(16_suppl). 611–611.
5.
Jacob, Saya, et al.. (2023). Crofelemer for the Management of Neratinib-Associated Diarrhea in Patients With HER2+ Early-Stage Breast Cancer. Clinical Breast Cancer. 23(7). 721–728. 2 indexed citations
6.
Jacob, Saya, et al.. (2023). Role of Immunotherapy in Breast Cancer. JCO Oncology Practice. 19(4). 167–179. 39 indexed citations
7.
Shastry, Mythili, Saya Jacob, Hope S. Rugo, & Erika Hamilton. (2022). Antibody-drug conjugates targeting TROP-2: Clinical development in metastatic breast cancer. The Breast. 66. 169–177. 81 indexed citations
8.
Zhang, Qiang, Weijun Qin, Paolo D’Amico, et al.. (2022). ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).. Journal of Clinical Oncology. 40(16_suppl). 1057–1057. 1 indexed citations
9.
Jacob, Saya, Andrew A. Davis, Lorenzo Gerratana, et al.. (2021). The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer. Clinical Cancer Research. 27(5). 1361–1370. 35 indexed citations
10.
Jacob, Saya, Andrew A. Davis, Paolo D’Amico, et al.. (2021). Abstract PS2-10: Circulating tumor DNA (ctDNA) as a diagnostic tool to identify putative germline BRCA mutations. Cancer Research. 81(4_Supplement). PS2–10. 1 indexed citations
11.
Shah, Ami N., Lorenzo Gerratana, Chenyu Lin, et al.. (2021). Circulating tumor cells, circulating tumor DNA, and disease characteristics in young women with metastatic breast cancer. Breast Cancer Research and Treatment. 187(2). 397–405. 15 indexed citations
12.
D’Amico, Paolo, Carolina Reduzzi, Sara Gandini, et al.. (2021). Correlation between different levels of HER2 expression in circulating tumor cells (cHER2 ratio) and metastatic behavior in stageIVaggressive breast cancer.. Journal of Clinical Oncology. 39(15_suppl). 3036–3036. 5 indexed citations
13.
D’Amico, Paolo, Qiang Zhang, Lorenzo Gerratana, et al.. (2021). Abstract PS2-11: Ctc-her2+ a novel subset in stage IVaggressive: Molecular correlations, outcome and clinical characteristics in metastatic breast cancer. Cancer Research. 81(4_Supplement). PS2–11. 3 indexed citations
14.
Shah, Ami N., Andrew A. Davis, Saya Jacob, et al.. (2021). Circulating tumor DNA (ctDNA) as a tool to help guide germline testing in patients with solid malignancies.. Journal of Clinical Oncology. 39(15_suppl). 10602–10602. 1 indexed citations
15.
Jacob, Saya, Lesli A. Kiedrowski, & Young Kwang Chae. (2020). The dynamic landscape of BRCA1 reversion mutations from indel to SNV in a patient with ovarian cancer treated with PARP-inhibitors and immunotherapy. Heliyon. 6(5). e03841–e03841. 9 indexed citations
16.
Davis, Andrew A., Saya Jacob, Lorenzo Gerratana, et al.. (2020). Landscape of circulating tumour DNA in metastatic breast cancer. EBioMedicine. 58. 102914–102914. 43 indexed citations
17.
Davis, Andrew A., Saya Jacob, Lorenzo Gerratana, et al.. (2020). Abstract P5-01-08: Landscape of circulating tumor DNA (ctDNA) in metastatic breast cancer. Cancer Research. 80(4_Supplement). P5–1. 1 indexed citations
18.
Jacob, Saya, Brian S. Finkelman, Jeffrey Zhao, et al.. (2020). The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapy. Oncotarget. 11(21). 1953–1960. 18 indexed citations
19.
Jacob, Saya, Kyle Tegtmeyer, Jeffrey Zhao, et al.. (2020). Lung Cancer Survival in Patients With Autoimmune Disease. JAMA Network Open. 3(12). e2029917–e2029917. 19 indexed citations
20.
Jacob, Saya, et al.. (2018). Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration. JNCI Cancer Spectrum. 2(2). pky012–pky012. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Minghan Jia Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by Benedetta Pellegrino Breakdown of academic impact, for papers by Shinsuke Tasaki Breakdown of academic impact, for papers by Netanya Pollock Breakdown of academic impact, for papers by Xiaojun Fan Breakdown of academic impact, for papers by Lauren Nye Breakdown of academic impact, for papers by Jennifer Marks Breakdown of academic impact, for papers by Xinnian Yu Breakdown of academic impact, for papers by Quchang Ouyang
Rankless by CCL
2026